Gilead Sciences Inc’s Truvada tablets appear safe and effective for reducing the risk of HIV infection, U.S. regulators said on Tuesday. But they recommended a cautious approach for using the drug in efforts to prevent the virus that causes AIDS. Continue reading
Meta
-
Recent Posts
- FDA staff: Gilead’s Truvada may help reduce HIV risk
- US experts back HIV prevention pill
- New AIDS stats give hope, sustained action still needed
- Living with HIV/AIDS in Myanmar
- Undernourished and anaemic – the plight of India’s teen girls
- Homily: AIDS/HIV/Hepatitis C Awareness Mass
- Understanding HIV/AIDS
- Pakistan: Call for Church to help AIDS fight
- HIV/AIDS: Be sensitive about it
- Note on the banalization of sexuality Regarding certain interpretations of “Light of the World”
- HIV + AIDS Treatment in Practice 188: TB, HIV, mothers and children: time for action
- Condom video stirs Buddhist resentment
- Over 1 million Thais are infected with HIV/AIDs
- The Way of the Cross for Caregivers of the Sick
- Caregivers’ Retreat
